Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles
Go back to Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles| (NASDAQ: BNTX) | Delayed: 100.87 +2.87 (2.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.00 | 52 Week High | $ | |||
| Open | $98.00 | 52 Week Low | $ | |||
| Day High | $102.23 | P/E | N/A | |||
| Day Low | $97.46 | EPS | $ | |||
| Volume | 1,050,279 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.93 +0.19 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.74 | 52 Week High | $37.39 | |||
| Open | $27.74 | 52 Week Low | $28.25 | |||
| Day High | $28.00 | P/E | 16.93 | |||
| Day Low | $27.49 | EPS | $1.65 | |||
| Volume | 26,656,774 | |||||
